180 related articles for article (PubMed ID: 33817651)
1. Improving Tumor Hypoxia Location in
Gertsenshteyn I; Epel B; Barth E; Leoni L; Markiewicz E; Tsai HM; Fan X; Giurcanu M; Bodero D; Zamora M; Sundramoorthy S; Kim H; Freifelder R; Bhuiyan M; Kucharski A; Karczmar G; Kao CM; Halpern H; Chen CT
Radiol Imaging Cancer; 2021 Mar; 3(2):e200104. PubMed ID: 33817651
[TBL] [Abstract][Full Text] [Related]
2. The optimal
Gertsenshteyn I; Epel B; Ahluwalia A; Kim H; Fan X; Barth E; Zamora M; Markiewicz E; Tsai HM; Sundramoorthy S; Leoni L; Lukens J; Bhuiyan M; Freifelder R; Kucharski A; Giurcanu M; Roman BB; Karczmar G; Kao CM; Halpern H; Chen CT
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4014-4024. PubMed ID: 35792927
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An
Mainta IC; Zilli T; Tille JC; De Perrot T; Vallée JP; Buchegger F; Garibotto V; Miralbell R
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1210-1218. PubMed ID: 29678527
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Tumor-associated Stroma and Its Relationship with Tumor Hypoxia Using Dynamic Contrast-enhanced CT and (18)F Misonidazole PET in Murine Tumor Models.
Koyasu S; Tsuji Y; Harada H; Nakamoto Y; Nobashi T; Kimura H; Sano K; Koizumi K; Hamaji M; Togashi K
Radiology; 2016 Mar; 278(3):734-41. PubMed ID: 26393963
[TBL] [Abstract][Full Text] [Related]
5. Tumoral hypoxia in osteosarcoma in rats: preliminary study of blood oxygenation level-dependent functional MRI and 18F-misonidazole PET/CT with diffusion-weighted MRI correlation.
Dallaudiere B; Hummel V; Hess A; Lincot J; Preux PM; Maubon A; Monteil J
AJR Am J Roentgenol; 2013 Feb; 200(2):W187-92. PubMed ID: 23345383
[TBL] [Abstract][Full Text] [Related]
6. Comparison of DCE-MRI kinetic parameters and FMISO-PET uptake parameters in head and neck cancer patients.
Simoncic U; Leibfarth S; Welz S; Schwenzer N; Schmidt H; Reischl G; Pfannenberg C; Fougère C; Nikolaou K; Zips D; Thorwarth D
Med Phys; 2017 Jun; 44(6):2358-2368. PubMed ID: 28317128
[TBL] [Abstract][Full Text] [Related]
7. Optimal timing of fluorine-18-fluoromisonidazole positron emission tomography/computed tomography for assessment of tumor hypoxia in patients with head and neck squamous cell carcinoma.
Chatterjee A; Gupta T; Rangarajan V; Purandare N; Kunder S; Murthy V; Budrukkar A; Ghosh-Laskar S; Agarwal J
Nucl Med Commun; 2018 Sep; 39(9):859-864. PubMed ID: 29939883
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Combretastatin A4-induced tumor hypoxia and hemodynamic changes using endogenous MR contrast and DCE-MRI.
Colliez F; Fruytier AC; Magat J; Neveu MA; Cani PD; Gallez B; Jordan BF
Magn Reson Med; 2016 Feb; 75(2):866-72. PubMed ID: 25765253
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.
Gupta T; Chatterjee A; Rangarajan V; Purandare N; Arya S; Murthy V; Budrukkar A; Ghosh-Laskar S; Agarwal JP
Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):162-170. PubMed ID: 31496204
[TBL] [Abstract][Full Text] [Related]
10. A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.
Tachibana I; Nishimura Y; Shibata T; Kanamori S; Nakamatsu K; Koike R; Nishikawa T; Ishikawa K; Tamura M; Hosono M
J Radiat Res; 2013 Nov; 54(6):1078-84. PubMed ID: 23589026
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
[TBL] [Abstract][Full Text] [Related]
12. Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort.
Riedl CC; Brader P; Zanzonico P; Reid V; Woo Y; Wen B; Ling CC; Hricak H; Fong Y; Humm JL
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):39-46. PubMed ID: 17786438
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.
Cho H; Ackerstaff E; Carlin S; Lupu ME; Wang Y; Rizwan A; O'Donoghue J; Ling CC; Humm JL; Zanzonico PB; Koutcher JA
Neoplasia; 2009 Mar; 11(3):247-59, 2p following 259. PubMed ID: 19242606
[TBL] [Abstract][Full Text] [Related]
14. EPR oxygen images predict tumor control by a 50% tumor control radiation dose.
Elas M; Magwood JM; Butler B; Li C; Wardak R; DeVries R; Barth ED; Epel B; Rubinstein S; Pelizzari CA; Weichselbaum RR; Halpern HJ
Cancer Res; 2013 Sep; 73(17):5328-35. PubMed ID: 23861469
[TBL] [Abstract][Full Text] [Related]
15. Concurrent Respiratory Motion Correction of Abdominal PET and Dynamic Contrast-Enhanced-MRI Using a Compressed Sensing Approach.
Fuin N; Catalano OA; Scipioni M; Canjels LPW; Izquierdo-Garcia D; Pedemonte S; Catana C
J Nucl Med; 2018 Sep; 59(9):1474-1479. PubMed ID: 29371404
[TBL] [Abstract][Full Text] [Related]
16. Machine learning identifies multi-parametric functional PET/MR imaging cluster to predict radiation resistance in preclinical head and neck cancer models.
Boeke S; Winter RM; Leibfarth S; Krueger MA; Bowden G; Cotton J; Pichler BJ; Zips D; Thorwarth D
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3084-3096. PubMed ID: 37148296
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging.
Carmona-Bozo JC; Manavaki R; Woitek R; Torheim T; Baxter GC; Caracò C; Provenzano E; Graves MJ; Fryer TD; Patterson AJ; Gilbert FJ
Eur Radiol; 2021 Jan; 31(1):333-344. PubMed ID: 32725330
[TBL] [Abstract][Full Text] [Related]
18. Methods for noninvasive imaging of tissue hypoxia.
Vikram DS; Zweier JL; Kuppusamy P
Antioxid Redox Signal; 2007 Oct; 9(10):1745-56. PubMed ID: 17663644
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.
Tateishi U; Miyake M; Nagaoka T; Terauchi T; Kubota K; Kinoshita T; Daisaki H; Macapinlac HA
Radiology; 2012 Apr; 263(1):53-63. PubMed ID: 22438441
[TBL] [Abstract][Full Text] [Related]
20. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
Zanzonico P; O'Donoghue J; Chapman JD; Schneider R; Cai S; Larson S; Wen B; Chen Y; Finn R; Ruan S; Gerweck L; Humm J; Ling C
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):117-28. PubMed ID: 14523586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]